Idarubicin API is a pharmaceutical-grade anthracycline antineoplastic agent used in the treatment of acute myeloid leukemia (AML) and other hematological malignancies. It acts by intercalating DNA and inhibiting topoisomerase II, preventing DNA replication and inducing apoptosis in rapidly dividing cancer cells.
Idarubicin is primarily formulated as injectable preparations for use in combination chemotherapy protocols. Due to its potent antitumor activity and improved cellular penetration, it is widely used in modern oncology treatment regimens.
Manufactured under WHO-GMP-certified facilities, our Idarubicin API provides exceptional purity, stability, and batch-to-batch consistency. Every batch is supplied with complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Idarubicin API is used in injectable chemotherapy formulations for the treatment of acute myeloid leukemia (AML) and other hematological cancers.
It intercalates DNA and inhibits topoisomerase II, disrupting DNA replication and triggering apoptosis in rapidly dividing cancer cells.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation.
Yes. We supply Idarubicin API in commercial quantities with worldwide export support.
Get Bulk Quote via WhatsApp